Publikationen
Zeitschriftenartikel (101)
1.
Zeitschriftenartikel
39 (4), S. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 2.
Zeitschriftenartikel
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 3.
Zeitschriftenartikel
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders (2024)
4.
Zeitschriftenartikel
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose (2024)
5.
Zeitschriftenartikel
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry (2024)
6.
Zeitschriftenartikel
22, S. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 7.
Zeitschriftenartikel
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 8.
Zeitschriftenartikel
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell (2024)
9.
Zeitschriftenartikel
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 10.
Zeitschriftenartikel
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 11.
Zeitschriftenartikel
147 (1), S. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain 12.
Zeitschriftenartikel
147 (1), 40 (2024)
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica 13.
Zeitschriftenartikel
18, S. 68 - 71 (2024)
Prion meeting 2023: implications of a growing field. Prion 14.
Zeitschriftenartikel
1869 (8), 166835 (2023)
Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta-Molecular Basis of Disease 15.
Zeitschriftenartikel
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry (2023)
16.
Zeitschriftenartikel
146, S. 369 - 385 (2023)
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica 17.
Zeitschriftenartikel
166 (5), S. 862 - 874 (2023)
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry 18.
Zeitschriftenartikel
38 (9), S. 1585 - 1597 (2023)
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders 19.
Zeitschriftenartikel
24 (17), 13435 (2023)
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 20.
Zeitschriftenartikel
29 (1), 111 (2023)
The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine 21.
Zeitschriftenartikel
39 (4-6), S. 321 - 335 (2023)
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling 22.
Zeitschriftenartikel
19 (8), S. 453 - 454 (2023)
AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews Neurology 23.
Zeitschriftenartikel
38 (7), S. 1127 - 1142 (2023)
Defining the riddle in order to solve it: There is more than one "Parkinson's Disease". Movement Disorders 24.
Zeitschriftenartikel
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry, in press (2023)
25.
Zeitschriftenartikel
123 (14), S. 9094 - 9138 (2023)
Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 26.
Zeitschriftenartikel
13 (4), S. 633 - 636 (2023)
People with early onset Parkinson’s disease: empowered to improve care. Journal of Parkinson's Disease: JPD 27.
Zeitschriftenartikel
29 (33), e202300649 (2023)
Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry – A European Journal 28.
Zeitschriftenartikel
14, 1918 (2023)
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 29.
Zeitschriftenartikel
13 (2), S. 179 - 196 (2023)
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 30.
Zeitschriftenartikel
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 31.
Zeitschriftenartikel
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 32.
Zeitschriftenartikel
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 33.
Zeitschriftenartikel
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 34.
Zeitschriftenartikel
38 (2), S. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 35.
Zeitschriftenartikel
12, S. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 36.
Zeitschriftenartikel
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 37.
Zeitschriftenartikel
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 38.
Zeitschriftenartikel
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
39.
Zeitschriftenartikel
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 40.
Zeitschriftenartikel
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 41.
Zeitschriftenartikel
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 42.
Zeitschriftenartikel
87, S. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 43.
Zeitschriftenartikel
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
44.
Zeitschriftenartikel
404, S. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 45.
Zeitschriftenartikel
116 (51), S. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 46.
Zeitschriftenartikel
28, S. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 47.
Zeitschriftenartikel
47, S. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 48.
Zeitschriftenartikel
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 49.
Zeitschriftenartikel
47 (3), S. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 50.
Zeitschriftenartikel
85 (5), S. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology